Deutsche Bank AG Form 38.5a (EPT/RI) - UDG Healthcare plc (4623I)
12 Agosto 2021 - 5:08AM
UK Regulatory
TIDM0H7D TIDMUDG
RNS Number : 4623I
Deutsche Bank AG
12 August 2021
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND
DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader Deutsche Bank AG London
Company dealt in UDG Healthcare plc
========================
Class of relevant security Ordinary Shares
to which the dealings being
disclosed relate (Note 1)
========================
Date of dealing 11/08/2021
========================
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of Highest price paid (Note Lowest price paid
relevant securities 3) (Note 3)
acquired
4,394 10.7900 GBP 10.7900 GBP
=============================== ====================
Total number of Highest price received (Note Lowest price received
securities disposed 3) (Note 3)
4,394 10.7884 GBP 10.7884 GBP
=================================== ========================
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 4) securities (Note 3)
(Note 5)
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option money
name, selling, securities price American, date paid/received
e.g. call purchasing, to which the European per unit
option varying option relates etc. (Note 3)
etc. (Note 5)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option
referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If
none, this should be stated.
None
Date of disclosure 12/08/2021
Contact name Gurpreet Kaur Kang
================================
Telephone number +44 121 407 8493
================================
Name of offeree/offeror with Nenelite Limited
which connected
================================
Nature of connection (Note 6) Financial Adviser and Corporate
Broker
================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEGZGMRGZNGMZM
(END) Dow Jones Newswires
August 12, 2021 06:08 ET (10:08 GMT)
Udg Healthcare Public (LSE:UDG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Udg Healthcare Public (LSE:UDG)
Gráfica de Acción Histórica
De May 2023 a May 2024